← Back to Search

Understanding Visual Confusion Using Stereoscopic Displays

N/A

Waitlist Available

Led By JaeHyun Jung

Research Sponsored by Massachusetts Eye and Ear Infirmary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 1-2 sessions to finish total 6 trials, up to 2 hours for each session, any time within the 4month study period

Awards & highlights

No Placebo-Only Group

Summary

This trial will help researchers understand how our brain processes information from what we see.

Eligible Conditions

Binocular Fusion Defect
Double vision
Double Vision
Binocular Vision Suppression

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 1-2 sessions to finish total 6 trials, up to 2 hours for each session, any time within the 4month study period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 1-2 sessions to finish total 6 trials, up to 2 hours for each session, any time within the 4month study period

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 1-2 sessions to finish total 6 trials, up to 2 hours for each session, any time within the 4month study period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percentage of Total Viewing Time That Peripheral Target is Perceived

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Visual confusionExperimental Treatment3 Interventions

Participants viewed peripheral targets in three different visual confusion conditions (three interventions): binocular visual confusion (unilateral opaque target), unilateral monocular visual confusion (unilateral see-through target), and bilateral monocular visual confusion (bilateral see-through target). Each intervention was presented twice in a randomized order, resulting in a total of six trials. During each trial, a peripheral target was presented in front of a forward-moving background for one minute. Participants were instructed to hold down the controller button while the target was visible and release it when a third or more of the target disappeared. After each trial, participants could take a brief break before the next trial in a different visual confusion condition was presented in a randomized order.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Bilateral monocular visual confusion (bilateral see-through)

2021

N/A

~20

Unilateral monocular visual confusion (unilateral see-through)

2021

N/A

~20